DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Dismiss
Open main menu
Search
For You
AI
Business
Crypto
Culture
Environment
Politics
Science
Sports
Tech
United States
World
Vyvgart News
Top stories
Company Earnings
Stocks
Pharma
argenx Reports Half Year 2025 Results with $949 Million Q2 Vyvgart Sales, $4 Billion Run Rate; Stock Surges 15%
Authors
6
2 days ago
Company Earnings
Pharma
Business
FDA Approves Apellis’ EMPAVELI for Rare Kidney Diseases in Patients 12+, Showing 68% Proteinuria Reduction; Q2 Revenue $178M
Authors
9
2 days ago
Latest stories
Latest stories
Jul 31, 2025
Jul 31, 2025
Company Earnings
Pharma
Business
FDA Approves Apellis’ EMPAVELI for Rare Kidney Diseases in Patients 12+, Showing 68% Proteinuria Reduction; Q2 Revenue $178M
Authors
9
2 days ago
Jul 31, 2025
Jul 31, 2025
Company Earnings
Stocks
Pharma
argenx Reports Half Year 2025 Results with $949 Million Q2 Vyvgart Sales, $4 Billion Run Rate; Stock Surges 15%
Authors
6
2 days ago
Previous
Next
Join our channels
Get the latest stories live on any device.
WhatsApp
Top Stories
Join
Telegram
Top Stories
Join
